Translational Sciences

With $1 billion to invest in life sciences startups, UPMC Enterprises will create a significant impact on patient care at UPMC while generating major financial returns that will fuel more scientific discoveries.

At UPMC, we are committed to building a health system where the right patient gets the right care, in the right way, at the right time, every time. The “Rights” of clinical management…

As 2019 comes to a close, we have seen many different trends and topics discussed on our blog. From new technologies and investments to breakthroughs in the digital health industry, we wanted to know what our team was most excited to see in 2020.

It has been a busy year at UPMC Enterprises. Here at the innovation and commercialization …

UPMC Enterprises has invested in a biotech startup company pursuing new approaches to boosting the …

The discussion, titled “Science or Science Fiction,” touched on a range of topics and, perhaps …

BlueSphere Bio, the first company to spin out of UPMC Enterprises’ Translational Sciences focus area, …

Less than 18 months later, that Enterprises team is nearly 20 strong and already seeing …

This year’s Pittsburgh Life Sciences Week will be taking place May 13 – May 17 …

UPMC Enterprises will play a key role in the new UPMC Immune Transplant and Therapy Center (ITTC), a $200 million project announced Feb. 13 that is harnessing the power of the human immune system to treat and cure a wide range of diseases.